Lori Friedman Director: Cancer Signaling & Translational Oncology Profile | Education/Background | Top Scientific Papers | Awards & Honors

"I joined Genentech in 2004 as part of Research Drug Discovery, and am currently Director of the Cancer Signaling and Translational Oncology department. I was attracted to Genentech because of the palpable commitment to helping patients by drawing on scientific insights."

Current Projects "The research in my department includes validation of oncology targets in intracellular signaling pathways, investigation of signaling networks, understanding mechanism of action of compounds, pharmacology, discovery and validation of preclinical PD assays, and predicting which patients will respond to new agents."

Collaborations "We work closely with groups throughout the company, including other departments in Research, Development Sciences, and Clinical. In addition we collaborate with a variety of external partners on drug discovery projects."

Inspiration/Vision "Making a difference to cancer patients has always been my goal. Knowing that my personal goal is in alignment with Genentech's goal is motivational."